Pharma Journalist -

“This milestone showcases the productivity of our collaboration with LEO Pharma, marking the final step before ARGX-112 may enter clinical development. It triggers the third of three…
Read More...

Ionis Pharmaceuticals announced that it has licensed IONIS-AZ6-2.5-LRx, or AZD2693, to AstraZeneca following advancement of the drug into development. IONIS-AZ6-2.5-LRx is designed to…
Read More...

Amgen announced plans to build a new state-of-the-art next-generation biomanufacturing plant at its campus in West Greenwich, R.I. The new plant, the first of its kind in the United…
Read More...

Alexion Pharmaceuticals and Wilson Therapeutics AB (publ) announced that Alexion has made a recommended public cash offer to the shareholders in Wilson Therapeutics to acquire all…
Read More...

Lonza is opening the world’s largest dedicated cell-and-gene-therapy facility, which was built in anticipation of the rising demand from developers of cell and gene therapies – the next…
Read More...

Halo Pharma, a rapidly growing contract development and manufacturing organization (CDMO), offers more than 30 years’ direct experience in the production of topical drug products – from…
Read More...

Bristol-Myers Squibb Company and the Harvard Fibrosis Network of the Harvard Stem Cell Institute announce a research collaboration to discover and develop potential new therapies for…
Read More...

Protagen AG and Gustave Roussy have announced the start of a collaboration to utilize Protagen’s SeroTag technology to help identify biomarkers that predict and monitor immune-related…
Read More...

Evotec AG announced a strategic collaboration with Petra Pharma Corporation. Through the collaboration, Petra will access Evotec's INDiGO platform to accelerate the development of its…
Read More...

Veracyte, Inc. announced a research collaboration through which Loxo Oncology will access Veracyte’s new Afirma Xpression Atlas platform to advance its development of highly selective…
Read More...